XmAb30819, an XmAb (R) 2+1 ENPP3 x CD3 bispecific antibody for RCC, demonstrates safety and efficacy in in vivo preclinical studies-MedSci.cn

XmAb30819, an XmAb (R) 2+1 ENPP3 x CD3 bispecific antibody for RCC, demonstrates safety and efficacy in in vivo preclinical studies

Nisthal, A; Lee, SH; Kim, YK; Bonzon, C; Rashid, R; Avery, KN; Bogaert, L; Ardila, C; Leung, IW; Rodriguez, N; Muchhal, US; Moore, GL; Chu, SY; Desjarlais, JR

CANCER RESEARCH, 2020; 80 (16):

科室
- - 订阅+
  - 更多科室
工具
服务